Altynay Sagymbay

ORCID: 0000-0002-2323-5043
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • Viral gastroenteritis research and epidemiology
  • Immune Response and Inflammation
  • COVID-19 Pandemic Impacts
  • interferon and immune responses
  • Economic, Social, and Public Health Issues in Russia and Globally
  • SARS-CoV-2 and COVID-19 Research

Institute for Biological Sciences
2019

Despite mass immunization against COVID-19, due to the high rate of spread, as well tendency rapidly change and recombine, SARS-CoV-2 virus caused several outbreaks (waves) disease around world. Thus, at end 2020, WHO announced emergence new variants SARS-CoV-2, which were associated with a wave COVID-19 cases. And beginning 2021, sequences B.1.1.7 variant, first identified in United Kingdom (UK) 2020 later called Alpha registered countries. In this regard, Kazakhstan, like other countries,...

10.53729/mv-as.2025.01.20 article RU МИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ 2025-03-26

The 2018/2019 influenza season in the WHO European Region was dominated by A (H1N1)pdm09 and (H3N2) viruses, with very few B viruses detected. Countries reported virus characterization data to Surveillance System for weeks 40/2018 20/2019. These antigenic genetic haemagglutinin (HA) sequence were analysed describe assess circulating relative vaccine components northern hemisphere. Thirty countries 4776 characterized genetically 3311 antigenically. All A(H1N1)pdm09 fell subclade 6B.1A, of...

10.1016/j.vaccine.2020.06.031 article EN cc-by Vaccine 2020-07-01

The producers of influenza vaccines are not capable today to meet the global demand for an vaccine in case pandemic, so World Health Organization recommends develop own production each country. A domestic preservative- and adjuvant-free trivalent split against seasonal was developed at Research Institute Biological Safety Problems. paper presents results assessing safety immunogenicity after single immunization healthy volunteers aged 18-50 years course Phase I Clinical Trials. This study...

10.1002/jmv.24922 article EN Journal of Medical Virology 2017-08-26

The paper describes the results of preclinical testing preparation "Vaccine allantoic split-virus inactivated against seasonal influenza." Acute toxicity and local irritating effect, anaphylactic reactions to different antigens (vaccine ovalbumin), delayed-type hypersensitivity ram erythrocytes, humoral immune response in hemaggtination reaction, immunogenic activity was studied laboratory animals various species (mice, rats, guinea pigs). Comparative analysis from under study commercial...

10.1002/jmv.24771 article EN Journal of Medical Virology 2017-02-04
Coming Soon ...